Diazepam (commonly known as Valium) is a Class IV controlled substance and a high-quality active pharmaceutical ingredient (API) manufactured in China. Produced under strict quality standards in GMP-certified facilities, it is a white to yellowish crystalline powder, with a CAS number of 439-14-5. As a potent benzodiazepine derivative, its mechanism of action involves enhancing the effects of the neurotransmitter GABA in the central nervous system (CNS), which suppresses abnormal neural activity.
This versatile API is widely utilized in the manufacturing of essential pharmaceutical preparations for the treatment of anxiety disorders, for inducing calm in acute agitation or pre-surgical sedation, for the management of status epilepticus and seizure disorders, for the relief of acute muscle spasms and spasticity, and for managing acute alcohol withdrawal symptoms.
Supplied in a secure fiber drum, it is produced in compliance with international pharmacopoeias (CP/BP/USP/EP). Important Notice: Diazepam is classified as a regulated pharmaceutical intermediate. Its procurement is subject to national controlled substances regulations. Potential buyers must demonstrate valid authorization and registration and possess a valid No Objection Certificate (NOC) from the relevant drug regulatory authority. It is intended strictly for authorized industrial, pharmaceutical, or research entities.













